JPH0314308B2 - - Google Patents

Info

Publication number
JPH0314308B2
JPH0314308B2 JP57141304A JP14130482A JPH0314308B2 JP H0314308 B2 JPH0314308 B2 JP H0314308B2 JP 57141304 A JP57141304 A JP 57141304A JP 14130482 A JP14130482 A JP 14130482A JP H0314308 B2 JPH0314308 B2 JP H0314308B2
Authority
JP
Japan
Prior art keywords
reaction
group
general formula
compound
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57141304A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5929667A (ja
Inventor
Michiaki Tominaga
Nagao Yo
Hidenori Ogawa
Kazuyuki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP57141304A priority Critical patent/JPS5929667A/ja
Publication of JPS5929667A publication Critical patent/JPS5929667A/ja
Publication of JPH0314308B2 publication Critical patent/JPH0314308B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57141304A 1982-08-13 1982-08-13 カルボスチリル誘導体および強心剤 Granted JPS5929667A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57141304A JPS5929667A (ja) 1982-08-13 1982-08-13 カルボスチリル誘導体および強心剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57141304A JPS5929667A (ja) 1982-08-13 1982-08-13 カルボスチリル誘導体および強心剤

Publications (2)

Publication Number Publication Date
JPS5929667A JPS5929667A (ja) 1984-02-16
JPH0314308B2 true JPH0314308B2 (enExample) 1991-02-26

Family

ID=15288771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57141304A Granted JPS5929667A (ja) 1982-08-13 1982-08-13 カルボスチリル誘導体および強心剤

Country Status (1)

Country Link
JP (1) JPS5929667A (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
JPS63301821A (ja) * 1986-03-05 1988-12-08 Otsuka Pharmaceut Co Ltd 抗不整脈剤
JP2576862B2 (ja) * 1986-03-05 1997-01-29 大塚製薬 株式会社 カルボスチリル誘導体
US5464833A (en) * 1992-08-19 1995-11-07 Otsuka Pharmaceutical Co., Ltd. Apoptosis regulating composition
BR112013006953A2 (pt) * 2010-09-29 2016-07-26 Intervet Int Bv composto, composições farmacêutica e anti-helmíntica, uso de um composto, kit, e, método de tratamento de uma doença
DK3738434T3 (da) 2011-12-28 2023-12-04 Global Blood Therapeutics Inc Mellemprodukter til opnåelse af substituerede benzaldehydforbindelser og fremgangsmåder til anvendelse deraf ved øgning af vævsoxygenering
WO2013102145A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR102280614B1 (ko) 2013-03-15 2021-07-21 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
AU2014237330A1 (en) 2013-03-15 2015-09-17 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
BR112015021982B1 (pt) 2013-03-15 2022-12-13 Global Blood Therapeutics, Inc Compostos e seus usos para a modulação de hemoglobina
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
SI3102208T2 (sl) 2014-02-07 2024-10-30 Global Blood Therapeutics, Inc. Kristalinični polimorf proste baze 2-hidroksi-6-((2-(1-izopropil-1H-pirazol-5-IL)piridin-3-IL)metoksi)- benzaldehida
US11020382B2 (en) 2015-12-04 2021-06-01 Global Blood Therapeutics, Inc. Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
AR108435A1 (es) 2016-05-12 2018-08-22 Global Blood Therapeutics Inc Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5883677A (ja) * 1981-11-11 1983-05-19 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JP2610883B2 (ja) * 1987-08-06 1997-05-14 健三 山口 入出力端子の切り換え方法

Also Published As

Publication number Publication date
JPS5929667A (ja) 1984-02-16

Similar Documents

Publication Publication Date Title
KR860001944B1 (ko) 카보스티릴 화합물의 제조방법
US4760064A (en) Carbostyril compounds, compositions containing same and processes for preparing same
JPH02191256A (ja) カルボスチリル誘導体及び該誘導体を含有する精神分裂病治療剤
JPS5929667A (ja) カルボスチリル誘導体および強心剤
JPS6320226B2 (enExample)
JPH0564141B2 (enExample)
EP0168003B1 (en) Oxindol compounds, compositions containing same and processes for preparing same
JPS6332069B2 (enExample)
JPH0215537B2 (enExample)
JPH0696555B2 (ja) カルボスチリル誘導体
JPS649315B2 (enExample)
JPH0544463B2 (enExample)
JP2531962B2 (ja) ベンゾヘテロ環誘導体
JPH0471069B2 (enExample)
JPS6412247B2 (enExample)
JPS6331445B2 (enExample)
AU2005244389B2 (en) 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2H-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
JPH0544462B2 (enExample)
JPH0471056B2 (enExample)
JPS643194B2 (enExample)
JPH0310620B2 (enExample)
JPH0442383B2 (enExample)
JPS6325585B2 (enExample)
JPH0249769A (ja) カルボスチリル誘導体
JPS639514B2 (enExample)